Response Genetics (RGDXQ) Stock Statistics & Valuation Metrics

Response Genetics has a market cap or net worth of $78.00. The enterprise value is ―.

Response Genetics has 38,795,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Response Genetics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Response Genetics is ―. Response Genetics’s PEG ratio is ―.

In the last 12 months, Response Genetics had revenue of 18.04M and earned -20.18M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -13.09M and capital expenditures -51.42K, giving a free cash flow of -13.14M billion.

Response Genetics pays an annual dividend of ―, resulting in a dividend yield of ―

Response Genetics upcoming earnings date is ―, ―.

Response Genetics as a current ratio of ―, with Debt / Equity ratio of 19.30%

In the past 12 months, Response Genetics has paid -1.18M in taxes.

Response Genetics EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Response Genetics has $1.73M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$9.21M billion.

Gross margin is 21.85%, with operating margin of ―, and net profit margin of ―.

The average price target for Response Genetics is ―, which is 11.43% higher than the current price. The consensus rating is ―